NI
ACOR

Numeric Investors’s Acorda Therapeutics ACOR Stock Holding History

Numeric Investors’s Portfolio ACOR Stock Details ACOR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q2 		– Sell
-145
Closed -$365K – 1198
2017
Q1 		$365K Buy
145
+2
+1% +$5.76K ﹤0.01% 859
2016
Q4 		$321K Sell
143
-1
-0.7% -$2.38K ﹤0.01% 904
2016
Q3 		$361K Buy
+144
New +$430K ﹤0.01% 891
2016
Q2 		– Sell
-119
Closed -$378K – 1209
2016
Q1 		$378K Buy
+119
New +$494K ﹤0.01% 796
2015
Q2 		– Sell
-1,431
Closed -$5.71M – 1116
2015
Q1 		$5.71M Buy
1,431
+1,050
+276% +$4.81M 0.07% 234
2014
Q4 		$1.87M Buy
+381
New +$1.63M 0.02% 354
2014
Q3 		– Sell
-53
Closed -$212K – 958
2014
Q2 		$212K Buy
+53
New +$216K ﹤0.01% 717

Other funds holding ACOR

SCM
Scopia Capital Management New York $146M AUM 25.93% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
PHS
PFM Health Sciences San Francisco, California $1.1B AUM 57.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return

Numeric Investors's ACOR Position: Q2 2017 in Review

Numeric Investors sold out of Acorda Therapeutics (ACOR) in Q2 2017, closing a stake of 145 shares — an estimated $365K sold.

Numeric Investors first reported a position in ACOR in Q2 2014 and held it in 7 quarters. The position peaked at $5.71M in Q1 2015. 151 funds tracked by Wall St. Rank hold ACOR as of Q2 2017.

  • Numeric Investors reported no remaining Acorda Therapeutics position as of Q2 2017 after selling out during the quarter.
  • Numeric Investors sold 145 Acorda Therapeutics shares in Q2 2017, an estimated $365K.
  • Numeric Investors first reported a position in Acorda Therapeutics in Q2 2014 and held it in 7 quarters.
  • Numeric Investors's Acorda Therapeutics position peaked at $5.71M in Q1 2015.
  • 151 funds tracked by Wall St. Rank held Acorda Therapeutics as of Q2 2017.

Based on Numeric Investors's 13F filing for Q2 2017, filed 14 Aug 2017.